We are live on ! Find out more
HCM

Harvey Capital Management Portfolio holdings

AUM $439M
1-Year Est. Return 37.68%
This Fund
S&P 500
This Quarter Est. Return
+5.22%
1 Year Est. Return
+37.68%
3 Year Est. Return
+140.63%
5 Year Est. Return
+188.51%
10 Year Est. Return
+681.53%
AUM
$296M
AUM Growth
+$23.5M
Cap. Flow
+$12.4M
Cap. Flow %
4.2%
Top 10 Hldgs %
46.08%
Holding
94
New
12
Increased
20
Reduced
15
Closed
6

Sector Composition

Rank Sector Weight
1 Healthcare 29.06%
2 Technology 22.16%
3 Communication Services 17.16%
4 Industrials 7.25%
5 Consumer Discretionary 4.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAPL icon
1
Apple
AAPL
$4.8T
$22.4M 7.59%
709,676
-3,300
-0.5% -$106K
ACAD icon
2
Acadia Pharmaceuticals
ACAD
$4.3B
$18.5M 6.27%
444,425
-58,875
-12% -$2.28M
CELG
3
DELISTED
Celgene Corp
CELG
$16.4M 5.55%
137,150
-9,850
-7% -$1.13M
TTPH
4
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$14.1M 4.76%
14,684
-1,211
-8% -$990K
GILD icon
5
Gilead Sciences
GILD
$165B
$13.9M 4.71%
120,950
-12,950
-10% -$1.42M
MNDT
6
DELISTED
Mandiant, Inc. Common Stock
MNDT
$12.1M 4.09%
250,900
+38,700
+18% +$1.75M
GOOG icon
7
Alphabet (Google) Class C
GOOG
$4.29T
$10.1M 3.43%
382,500
+3,663
+1% +$98.1K
EMC
8
DELISTED
EMC CORPORATION
EMC
$9.82M 3.32%
370,450
+2,500
+0.7% +$66.7K
PARA
9
DELISTED
Paramount Global Class B
PARA
$9.72M 3.29%
175,050
-950
-0.5% -$57.4K
PFPT
10
DELISTED
Proofpoint, Inc.
PFPT
$9.09M 3.08%
142,935
+81,800
+134% +$4.81M
TWX
11
DELISTED
Time Warner Inc
TWX
$8.62M 2.92%
97,416
-200
-0.2% -$17.1K
NKTR icon
12
Nektar Therapeutics
NKTR
$2.19B
$7.37M 2.49%
41,313
+20,393
+97% +$3.51M
CEMP
13
DELISTED
Cempra, Inc.
CEMP
$7.29M 2.47%
218,450
+3,300
+2% +$117K
ORCL icon
14
Oracle
ORCL
$350B
$7.22M 2.44%
178,900
+54,550
+44% +$2.37M
PTLA
15
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$7.11M 2.41%
155,030
+5,350
+4% +$215K
BABA icon
16
Alibaba
BABA
$288B
$6.93M 2.35%
84,460
+28,735
+52% +$2.47M
BKNG icon
17
Booking.com
BKNG
$139B
$6.66M 2.25%
145,750
+6,875
+5% +$328K
NVAX icon
18
Novavax
NVAX
$1.3B
$6.66M 2.25%
30,598
-250
-0.8% -$43.9K
WBD icon
19
Warner Bros
WBD
$64.8B
$5.11M 1.73%
154,125
+92,525
+150% +$3.05M
OUT icon
20
Outfront Media
OUT
$5.75B
$4.74M 1.6%
193,247
-697
-0.4% -$19.2K
AAL icon
21
American Airlines Group
AAL
$10B
$4.26M 1.44%
+109,050
New +$4.97M
CBI
22
DELISTED
Chicago Bridge & Iron Nv
CBI
$4.14M 1.4%
82,951
+200
+0.2% +$10.4K
PRU icon
23
Prudential Financial
PRU
$41B
$4.07M 1.38%
46,187
QCOM icon
24
Qualcomm
QCOM
$180B
$3.95M 1.34%
62,620
+150
+0.2% +$10.2K
AERI
25
DELISTED
Aerie Pharmaceuticals
AERI
$3.86M 1.3%
223,200
+75,800
+51% +$1.39M

Similar funds

Harvey Capital Management's Q2 2015 Portfolio in Review

As of Q2 2015, Harvey Capital Management held 94 positions worth $296M, up 8.6% from $272M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Harvey Capital Management deployed $12.4M of net new capital in Q2 2015, opening 12 new positions and adding to 20 existing holdings. Its largest new stake was American Airlines Group: 109,050 shares worth $4.26M.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, up from 26% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was GE Aerospace, an estimated $4.74M trimmed.

  • Harvey Capital Management's largest Q2 2015 buy was American Airlines Group: 109,050 shares worth $4.26M.
  • Harvey Capital Management added most to Proofpoint, Inc. in Q2 2015, an estimated $4.81M increase.
  • Harvey Capital Management's biggest Q2 2015 reduction was GE Aerospace, cutting an estimated $4.74M.
  • Harvey Capital Management fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $4.58M.
  • Harvey Capital Management's ten largest holdings make up 46% of its $296M portfolio in Q2 2015.
  • Harvey Capital Management opened 12 new positions and closed 6 in Q2 2015.
  • Harvey Capital Management's portfolio value rose 8.6% quarter-over-quarter to $296M.

Based on Harvey Capital Management's 13F filing for Q2 2015, filed 22 Jul 2015.